Precigen, Inc. Income from Discontinued Operations

Income from Discontinued Operations of PGEN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Income from Discontinued Operations growth rates and interactive chart.


Highlights and Quick Summary

  • Income from Discontinued Operations for the quarter ending June 30, 2022 was $8.42 Million (a Infinity% increase compared to previous quarter)
  • Year-over-year quarterly Income from Discontinued Operations increased by 13940.0%
  • Annual Income from Discontinued Operations for 2021 was $4.6 Million (a -106.89% decrease from previous year)
  • Annual Income from Discontinued Operations for 2020 was $-66.7 Million (a -56.54% decrease from previous year)
  • Annual Income from Discontinued Operations for 2019 was $-154 Million (a 14.43% increase from previous year)
  • Twelve month Income from Discontinued Operations ending June 30, 2022 was $-2.39 Million (a -3376.71% decrease compared to previous quarter)
  • Twelve month trailing Income from Discontinued Operations decreased by -117.72% year-over-year
Trailing Income from Discontinued Operations for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
$-2.39 Million $73 Thousand $4.6 Million $13.5 Million
Visit stockrow.com/PGEN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Income from Discontinued Operations of Precigen, Inc.

Most recent Income from Discontinued Operationsof PGEN including historical data for past 10 years.

Interactive Chart of Income from Discontinued Operations of Precigen, Inc.

Precigen, Inc. Income from Discontinued Operations for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $8.42 $0.0
2021 $-10.88 $0.06 $10.89 $4.53 $4.6
2020 $-1.98 $-1.97 $-27.65 $-35.15 $-66.75
2019 $-133.14 $-4.58 $-6.63 $-9.24 $-153.58
2018 $-134.22
2017 $-46.38

Business Profile of Precigen, Inc.

Sector: Healthcare
Industry: Biotechnology